FDA comes under fire from prestigious medical journal
6332
Drug maker Bayer was slow to report the risks of its cholesterol-lowering drug Baycol and to remove it from the market in 2001, according to an forthcoming report in the Journal of the American Medical Association.
130395
Critics charge conflict of interest in a system where pharmaceutical giants fund the regulatory process. By Alexandra Marks | Staff writer of The Christian Science Monitor.
167369
One of the world&#39;s leading medical journals has blasted China&#39;s first-ever Grand Prix, due to take place in Shanghai on Sunday, for bringing Formula One and Big Tobacco together in &quot;a race to the death.
713661
CHICAGO -- The lead author and peer reviewers of a government report raising the possibility of public health threats from industrial contamination throughout the Great Lakes region are charging that the report is being suppressed because of the questions it raises. The author also alleges that h...
104187
The Bush administration and some of its critics squared off yesterday over whether the Food and Drug Administration (FDA) is doing an adequate job overseeing drug safety, and whether the agency needs major reforms.
335462
Description: A consortium of leading medical journals wants to prevent publication of clinical trial results that overemphasize positive data.
733895
Media watchdog issues unprecedented, stinging rebuke for serious error of judgment.
402693
A series of articles critical of past trials of an important AIDS drug has created a furor in Africa, causing many public health experts to worry that some countries will stop using
224422
New reports accuse another drug company of being too slow to pull a dangerous medication from the market and question the ability of the US federal Food and Drug Administration to protect Americans from such risks.
737440
An unsurprising response from the FDA.
31437
The recent Vioxx withdrawal and testimony from an FDA insider accusing the agency of failing to protect public health are fueling such heightened concern over drug safety that valuable medicines could be kept from patients, doctors said on Friday.
69180
FDA commissioner Andrew von Eschenbach took a tongue-lashing from members of Congress over the way his agency handled Avandia, the diabetes drug from GlaxoSmithKline that has come under scrutiny for alleged heart attack risks.
185982
The editors of the Journal of the American Medical Association (JAMA) are calling for an end to the US Food and Drug Administration&#39;s (FDA) role in post-market monitoring of the safety of drugs it approves.
90458
The move comes ahead of a House hearing this week where, it is expected, drug companies will be excoriated for refusing to publish unfavorable clinical trial results.
262080
There are two problems at the FDA. The first is that the Fraud and Drug Administration clearly puts the protection of Big Pharma profits as its primary mission, rather than protecting the public from dangerous drugs.
129442
Dr. Marcia Angell, a pathologist and former editor of The New England Journal of Medicine, is taking on the American pharmaceutical industry.
730173
TORONTO - Some of the world&#39;s most prestigious medical journals have banded together to force pharmaceutical and medical device companies to report the full results of clinical trials, both positive and negative.